Regulation and role of arachidonate cascade during changes in life cycle of adipocytes

被引:0
作者
Shan Lu
Kohji Nishimura
Mohammad A. Hossain
Mitsuo Jisaka
Tsutomu Nagaya
Kazushige Yokota
机构
[1] Shimane University,Department of Life Science and Biotechnology
来源
Applied Biochemistry and Biotechnology | 2004年 / 118卷
关键词
Adipocyte; life cycle; peroxisome proliferator-activated receptor γ; adipogenesis; arachidonate cascade; eicosanoid; cyclooxygenase; prostaglandin; isoforms;
D O I
暂无
中图分类号
学科分类号
摘要
Although some eicosanoids serve as potent natural ligands to activate peroxisome proliferator-activated receptor (PPARγ), the ability of adipocytes to produce eicosanoids and regulate PPARγ remains unclear. Here, adipogenic 3T3-L1 cells were employed to determine the gene expression of isoforms of biosynthetic enzymes in the arachidonate cyclooxygenase (COX) pathway and the synthesis of prostaglandins (PGs). The expression of COX-2 was induced transiently in a biphasic manner upon the triggering of the differentiation and maturation phases while COX-1 was constitutive. The exclusive expression of lipocalin-type PGD synthase occurred and gradually increased during the maturation process along with the stable expression of PPARγ. Moreover, we confirmed the formation of PGD2 from arachidonic acid by the mature adipocytes, suggesting conversion into PGJ2 derivatives. Even though cytosolic and membrane-associated subtypes of PGE synthase were expressed at relatively constant levels, the ability of preadipocytes to produce PGE2 was greater than that of mature adipocytes in the cell response. The treatment of the mature adipocytes with exogenous PGD2, 15-deoxy-Δ12,14-PGJ2 and PGE2, in the presence of aspirin, enhanced the adipogenesis. These findings imply the specific roles of prostanoids produced by the mature adipocytes in the maintenance of terminal differentiation through an autocrine control mechanism.
引用
收藏
页码:133 / 153
页数:20
相关论文
共 158 条
  • [1] Needleman P.(1986)undefined Annu. Rev. Biochem. 55 69-102
  • [2] Turk J.(1992)undefined Biochim. Biophys. Acta 1128 117-131
  • [3] Jakschik B. A.(2000)undefined Annu. Rev. Biochem. 69 145-182
  • [4] Morrison A. R.(1983)undefined J. Biol. Chem. 258 11713-11718
  • [5] Lefkowith J. B.(2002)undefined J. Biol. Chem. 277 10,459-10,466
  • [6] Yamamoto S.(1987)undefined J. Pharmacol. Exp. Ther. 242 306-311
  • [7] Smith W. L.(2002)undefined Prostaglandins Other Lipid Mediat. 68–69 383-399
  • [8] DeWitt D. L.(1996)undefined Biochim. Biophys. Acta 1302 93-109
  • [9] Garavito R. M.(1997)undefined J. Biol. Chem. 272 5367-5370
  • [10] Fitzpatrick F. A.(1995)undefined Cell 83 803-812